top of page
PIPs logo updated.png

Proteins of the Immune System in Psychosis (PIPs) Study

A research study being conducted through the Translational Neurobiology Group, with collaborations through Melbourne Health and the Florey Institute of Neuroscience and Mental Health 

Schizophrenia is a serious mental illness that affects roughly 1% of the population. It may cause people to see, hear, taste or believe things that are not real. Schizophrenia typically appears during adolescence and young adulthood, but later onset is possible. Living with schizophrenia can be extremely difficult, especially if it goes untreated. The cause of schizophrenia is still unknown.


The PIPs study is investigating if there are changes in the brain that may explain why a person develops schizophrenia. To do this we aim to explore the role of the immune system in people with recently diagnosed schizophrenia and people without schizophrenia to see if the immune system affects how the brain develops.

We are aiming to recruit two groups of participants:

People within the first 5 years of a schizophrenia diagnosis

People from the general community


Both groups must be between the ages of 18 – 40 years old.


Other eligibility criteria are required. If you think you may be eligible to participate in the PIPs study, click here to find out more.

If you would like background information about the study and some more information about schizophrenia, please read below.

This research project is funded by the National Health and Medical Research Council.

bottom of page